Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P070008/S171

Edora 8 HF-T QP 407137 Edora 8 HF-T 407138 Evity 8 HF-T QP 407139 Evity 8 HF-T 407140 Enitra 8 HF-T QP 407141 Enitra 8 H

Biotronik, Inc. · Decision date Oct 16, 2025

FDA DECISIONP070008/S171

What did the FDA decide?

FDA records P070008/S171 as a supplement to PMA P070008, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 16, 2025.

FDA approval order statement

introducing an alternative supplier for a set screw component
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P070008/S171
Regulatory pathway
PMA supplement
Product code
NKE
Decision code
OK30
Decision date
Oct 16, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P).

Product code
NKE
FDA device class
3

For the original device and its historical approval scope, see PMA P070008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P070008 · Original PMA

    STRATOS LV CRT-P AND STRATOS LV-T CRT-P, COROX OTW BP LEAD AND COROX OTW-S BP LEAD

  2. P070008/S169 · Related supplement

    Edora 8 HF-T QP (407137); Edora 8 HF-T (407138); Evity 8 HF-T QP (407139); Evity 8 HF-T (407140); Enitra 8 HF-T QP (4071

  3. P070008/S170 · Related supplement

    Edora 8 HF-T QP 407137; Edora 8 HF-T 407138; Evity 8 HF-T QP 407139; Evity 8 HF-T 407140; Enitra 8 HF-T QP 407141; Enitr

  4. P070008/S171 received

    Application receipt date recorded by FDA.

  5. P070008/S171 · FDA decision

    30-Day Notice

  6. P070008/S167 · Related supplement

    Edora 8 HF-T QP; Edora 8 HF-T; Evity 8 HF-T QP; Evity 8 HF-T; Enitra 8 HF-T QP; Enitra 8 HF-T; Enticos 8 HF-T QP; Entico

  7. P070008/S173 · Related supplement

    Sentus ProMRI OTW QP S-75; Sentus ProMRI OTW QP S-85; Sentus ProMRI OTW QP S-95; Sentus ProMRI OTW QP L-75; Sentus ProMR

  8. P070008/S174 · Related supplement

    STRATOS LV CRT-P AND STRATOS LV-T CRT-P, COROX OTW BP LEAD AND COROX OTW-S BP LEAD

  9. P070008/S176 · Related supplement

    Edora 8 HF-T QP (407137); Edora 8 HF-T (407138); Evity 8 HF-T QP (407139); Evity 8 HF-T (407140); Enitra 8 HF-T QP (4071

  10. P070008/S178 · Related supplement

    Edora 8 HF-T QP, Edora 8 HF-T, Evity 8 HF-T QP, Evity 8 HF-T, Enitra 8 HF-T QP, Enitra 8 HF-T, Amvia Sky HF-T, Amvia Sky

  11. P070008/S172 · Related supplement

    Edora 8 HF-T QP 407137 Edora 8 HF-T 407138 Evity 8 HF-T QP 407139 Evity 8 HF-T 407140 Enitra 8 HF-T QP 407141 Enitra 8 H

  12. P070008/S182 · Related supplement

    Edora 8 HF-T QP Edora 8 HF-T Evity 8 HF-T QP Evity 8 HF-T Enitra 8 HF-T QP Enitra 8 HF-T Enticos 8 HF-T QP Enticos 8 HF-

  13. P070008/S181 · Related supplement

    Edora 8 HF-T QP 407137; Edora 8 HF-T 407138; Evity 8 HF-T QP 407139; Evity 8 HF-T 407140; Enitra 8 HF-T QP 407141; Enitr

  14. P070008/S183 · Related supplement

    Edora 8 HF-T QP, Edora 8 HF-T, Evity 8 HF-T QP, Evity 8 HF-T, Enitra 8 HF-T QP, Enitra 8 HF-T

  15. P070008/S184 · Related supplement

    Sentus ProMRI OTW QP S-75, Sentus ProMRI OTW QP S-85, Sentus ProMRI OTW QP S-95, Sentus ProMRI OTW QP L-75, Sentus ProMR

Timeline entries are records held by MedtechLedger for P070008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070008

Product / regulatory recordCompanyPathwayDecision dateSource
Biotronik, Inc.PMA approvalMay 12, 2008FDA
Biotronik, Inc.PMA supplementSep 11, 2025FDA
Biotronik, Inc.PMA supplementSep 15, 2025FDA
Biotronik, Inc.PMA supplementOct 24, 2025FDA
Biotronik, Inc.PMA supplementDec 10, 2025FDA
Biotronik, Inc.PMA supplementFeb 3, 2026FDA
Biotronik, Inc.PMA supplementMar 5, 2026FDA
Renamic NeoP070008/S175
Biotronik, Inc.PMA supplementApr 24, 2026FDA
Biotronik, Inc.PMA supplementMay 7, 2026FDA
Biotronik, Inc.PMA supplementSep 17, 2026FDA
Biotronik, Inc.PMA supplementSep 25, 2026FDA
Biotronik, Inc.PMA supplementOct 5, 2026FDA
Biotronik, Inc.PMA supplementOct 9, 2026FDA
Biotronik, Inc.PMA supplementOct 13, 2026FDA
BIOexpressP070008/S177
Biotronik, Inc.PMA supplementOct 16, 2026FDA
Biotronik, Inc.PMA supplementOct 22, 2026FDA

Explore the linked device profile

Other records with product code NKE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records